{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:23:14Z","timestamp":1757614994669,"version":"3.44.0"},"reference-count":15,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"6","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: Some primary aldosteronism (PA) patients with spontaneous hypokalemia achieved incomplete remission after surgical treatment. In this study, we aimed to construct a nomogram to predict surgical benefits for primary aldosteronism (PA) patients with typical symptoms, incorporating changes in plasma aldosterone, plasma renin activity (PRA), and aldosterone\/renin ratio (ARR) to help clinicians assess prognosis and develop optimised treatment plans. Methods: This retrospective cohort study enrolled 162 patients between January 2017 and January 2024. Baseline characteristics, clinical indicators, and biochemical results, including plasma aldosterone, PRA, ARR, and serum potassium, were compared among patients with different clinical and biochemical outcomes. A nomogram was developed and internally validated with risk factors selected from univariate and multivariate logistic regression analyses. Results: Complete clinical and biochemical success was achieved in 69 (42.6%) and 129 (79.6%). Five risk factors were used to develop a nomogram. The area under the receiver operating characteristic curve (AUC) was 0.856 (0.788-0.924) in the training dataset and 0.726 (0.580-0.872) in the validation dataset. The calibration curve showed good agreement, and the decision curve analysis demonstrated the clinical utility of this model. Conclusions: PA patients with older age, higher systolic blood pressure, lower plasma aldosterone, more than 5 years of hypertension, and an adrenal gland mass on the left side or both sides had more probability of achieving incomplete remission after the surgery.<\/jats:p>","DOI":"10.5937\/jomb0-54960","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T03:09:22Z","timestamp":1744340962000},"page":"1227-1240","source":"Crossref","is-referenced-by-count":0,"title":["The prognosis of primary aldosteronism achieved incomplete surgical remission and changes in plasma aldosterone, plasma renin activity, and biochemical indicators"],"prefix":"10.5937","volume":"44","author":[{"given":"Zihao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenliang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol 2022; 18(11): 665-82.;","DOI":"10.1038\/s41574-022-00730-2"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mosso L, Carvajal C, Gonz\u00e1lez A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42(2): 161-5.;","DOI":"10.1161\/01.HYP.0000079505.25750.11"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2018; 6(1): 41-50.;","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89(3): 1045-50.;","DOI":"10.1210\/jc.2003-031337"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Burrello J, Monticone S, Losano I, Cavagli\u00e0 G, Buffolo F, Tetti M, et al. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertens Dallas Tex 1979 2020; 75(4): 1025-33.;","DOI":"10.1161\/HYPERTENSIONAHA.119.14063"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101(5): 1889-916.;","DOI":"10.1210\/jc.2015-4061"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zhang M, Bian G, Tian J, Yang W, Wang X, Chi C. Assessment of biochemical outcomes in patients with primary aldosteronism after adrenalectomy based on CT scan diagnosis of unilateral adenoma without adrenal vein sampling. Front Oncol 2022; 12: 944035.;","DOI":"10.3389\/fonc.2022.944035"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Dekkers T, Prejbisz A, Kool LJS, Groenewoud HJMM, Velema M, Spiering W, et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol 2016; 4(9): 739-46.;","DOI":"10.1016\/S2213-8587(16)30100-0"},{"key":"ref9","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5(9): 689-99.;"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159-219.;","DOI":"10.1093\/eurheartj\/eht151"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, et al. Primary aldosteronism: factors associated with normalisation of blood pressure after surgery. Ann Intern Med 2001; 135(4): 258-61.;","DOI":"10.7326\/0003-4819-135-4-200108210-00010"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150(11): 776-83.;","DOI":"10.7326\/0003-4819-150-11-200906020-00005"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, et al. Lateralising asymmetry of adrenal imaging and adrenal vein sampling in patients with primary aldosteronism. J Endocr Soc 2019; 3(7): 1393-402.;","DOI":"10.1210\/js.2019-00131"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Otsuka H, Abe M, Kobayashi H. The effect of aldosterone on cardiorenal and metabolic systems. Int J Mol Sci 2023; 24(6): 5370.;","DOI":"10.3390\/ijms24065370"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Li J, Li C, Zhu G, Yang J, Zhang Y, Yu Z, et al. A novel nomogram to predict survival of patients with hepatocellular carcinoma after transarterial chemoembolisation: a tool for retreatment decision making. Ann Transl Med 2023; 11(2): 68.;","DOI":"10.21037\/atm-22-6513"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Prognoza primarnog aldosteronizma u vezi sa nepotpunom hirur\u0161kom remisijom i promenama u nivou aldosterona u plazmi, aktivnosti renina u plazmi i biohemijskim pokazateljima"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582506227G.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:16:15Z","timestamp":1757070975000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582506227G"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-54960","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"type":"print","value":"1452-8258"},{"type":"electronic","value":"1452-8266"}],"subject":[],"published":{"date-parts":[[2025]]}}}